Literature DB >> 3222065

Basal ganglion calcification in hyperphenylalaninemia due to deficiency of dihydropteridine reductase.

H Schmidt1, K Ullrich, R Korinthenberg, P E Peters.   

Abstract

The disease course and therapy of a nine-and-a-half-year-old boy with hyperphenylalaninemia due to a dihydropteridine reductase deficiency are reported. Clinically, there is a marked mental retardation and complex basal ganglion symptoms. The cranial computed tomographic investigation shows bilateral, symmetrical, comma-shaped calcifications in the globus pallidus and the putamen of the lentiform nucleus. The cause of these basal ganglion calcifications remains unclear. Lowering of serum and CSF folic acid levels could not be detected, in contrast to cases with the same enzyme defect described previously.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3222065     DOI: 10.1007/bf02388415

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  20 in total

1.  Coincidence of Fahr disease and phenylketonuria.

Authors:  C E Parker; B H Landing
Journal:  J Pediatr       Date:  1977-08       Impact factor: 4.406

2.  [Hyperphenylalaninaemia with normal phenylalanine-hydroxylase activity and a deficiency of tetrahydrobiopterin and dihydropteridine reductase].

Authors:  F Rey; J P Harpey; R J Leeming; J A Blair; J Aicardi; J Rey
Journal:  Arch Fr Pediatr       Date:  1977 Aug-Sep

3.  Hyperphenylalaninaemia due to dihydropteridine reductase deficiency.

Authors:  H Gröbe; K Bartholome; S Milstien; S Kaufman
Journal:  Eur J Pediatr       Date:  1978-09-08       Impact factor: 3.183

4.  Partial purification and characterization of tryptophan hydroxylase from rabbit hindbrain.

Authors:  P A Friedman; A H Kappelman; S Kaufman
Journal:  J Biol Chem       Date:  1972-07-10       Impact factor: 5.157

5.  [Biopterin synthesis defects: complete deficiencies (reductase and synthetase)].

Authors:  J P Harpey
Journal:  Arch Fr Pediatr       Date:  1983

6.  Letter: Inborn error of carnitine metabolism ("carnitine deficiency") in man.

Authors:  D P Smyth; B D Lake; J MacDermot; J Wilson
Journal:  Lancet       Date:  1975-05-24       Impact factor: 79.321

7.  The blood-brain barrier and folate deficiency.

Authors:  M I Botez; J Bachevalier
Journal:  Am J Clin Nutr       Date:  1981-09       Impact factor: 7.045

8.  A sibling case of hyperphenylalaninemia due to a deficiency of dihydropteridine reductase: biochemical and pathological findings.

Authors:  K Tada; K Narisawa; N Arai; Y Ogasawara; S Ishizawa
Journal:  Tohoku J Exp Med       Date:  1980-10       Impact factor: 1.848

9.  Letter: L-dopa and 5-hydroxytryptophan therapy in phenylketonuria with normal phenylalanine-hydroxylase activity.

Authors:  K Bartholomé; D J Byrd
Journal:  Lancet       Date:  1975-11-22       Impact factor: 79.321

Review 10.  Histopathology of CNS leukemia and complications of therapy.

Authors:  R A Price
Journal:  Am J Pediatr Hematol Oncol       Date:  1979
View more
  4 in total

1.  Diffusion tensor images in children with early-treated, chronic, malignant phenylketonuric: correlation with intelligence assessment.

Authors:  Steven Shinn-Forng Peng; Wen-Yih Isaac Tseng; Yin-Hsiu Chien; Wuh-Liang Hwu; Hon-Man Liu
Journal:  AJNR Am J Neuroradiol       Date:  2004-10       Impact factor: 3.825

2.  Cranial CT and MRI in malignant phenylketonuria.

Authors:  F Gudinchet; P Maeder; R A Meuli; T Deonna; J M Mathieu
Journal:  Pediatr Radiol       Date:  1992

3.  Cranial MR spectroscopy of tetrahydrobiopterin deficiency.

Authors:  Yin-Hsiu Chien; Shiin-Feng Peng; Tso-Ren Wang; Wuh-Liang Hwu
Journal:  AJNR Am J Neuroradiol       Date:  2002 Jun-Jul       Impact factor: 3.825

4.  Tetrahydrobiopterin deficiencies: Lesson from clinical experience.

Authors:  Ayse Ergul Bozaci; Esra Er; Havva Yazici; Ebru Canda; Sema Kalkan Uçar; Merve Güvenc Saka; Cenk Eraslan; Hüseyin Onay; Sara Habif; Beat Thöny; Mahmut Coker
Journal:  JIMD Rep       Date:  2021-02-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.